Accelerated Vascular Aging as a Paradigm for Hypertensive Vascular Disease: Prevention and Therapy.
Aging is considered the most important nonmodifiable risk factor for cardiovascular disease and death after age 28 years. Because of demographic changes the world population is expected to increase to 9 billion by the year 2050 and up to 12 billion by 2100, with several-fold increases among those 65 years of age and older. Healthy aging and prevention of aging-related diseases and associated health costs have become part of political agendas of governments around the world. Atherosclerotic vascular burden increases with age; accordingly, patients with progeria (premature aging) syndromes die from myocardial infarctions or stroke as teenagers or young adults. The incidence and prevalence of arterial hypertension also increases with age. Arterial hypertension-like diabetes and chronic renal failure-shares numerous pathologies and underlying mechanisms with the vascular aging process. In this article, we review how arterial hypertension resembles premature vascular aging, including the mechanisms by which arterial hypertension (as well as other risk factors such as diabetes mellitus, dyslipidemia, or chronic renal failure) accelerates the vascular aging process. We will also address the importance of cardiovascular risk factor control-including antihypertensive therapy-as a powerful intervention to interfere with premature vascular aging to reduce the age-associated prevalence of diseases such as myocardial infarction, heart failure, hypertensive nephropathy, and vascular dementia due to cerebrovascular disease. Finally, we will discuss the implementation of endothelial therapy, which aims at active patient participation to improve primary and secondary prevention of cardiovascular disease.
Molecular Internal Medicine, University of Zürich, Zürich, Switzerland. Electronic address: barton@access.uzh.ch.
Matthias
M
Barton
Division of Angiology, University Hospital Zürich, Zürich, Switzerland.
Marc
M
Husmann
Division of Cardiology, Kantonsspital Aarau, Aarau, Switzerland.
Matthias R
MR
Meyer
D000375:Aging; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D015140:Dementia, Vascular / Q000150:complications; D048909:Diabetes Complications / Q000517:prevention & control; D050171:Dyslipidemias / Q000150:complications; D006333:Heart Failure / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000503:physiopathology* / Q000517:prevention & control* / Q000628:therapy; D006977:Hypertension, Renal / Q000150:complications; D007676:Kidney Failure, Chronic / Q000150:complications; D009203:Myocardial Infarction / Q000150:complications; D009393:Nephritis / Q000150:complications; D012307:Risk Factors; D059289:Vascular Stiffness
D000959:Antihypertensive Agents